Document:

EX-10.29

 

Exhibit 10.29

EXHIBITION TOUR AGREEMENT

THIS EXHIBITION TOUR AGREEMENT is entered into as of the 24th day of January, 2006 by and between
Premier Exhibitions 2005-ATL, Inc. (a corporation organized under the laws of the State of Nevada
and having its principal place of business at 3340 Peachtree Rd. NE, Atlanta, Georgia 30326
(“PREMIER”), and Dr. Hong-Jin Sui (“Dr. Sui”), a designer and supplier of all specimens referred to
herein, and Dr. Shuyan Wang President of Dalian Hoffen Bio Technique Company Limited collectively
referred to as (“DHBTL”) having a place of business in Dalian, China.

     WHEREAS, DHBTL is the owner of an Exhibition of Plastinated anatomical specimens including but
not limited to 20 full body Plastinated Human Bodies, 156 individual organs and all related
exhibition display materials including, but not limited to, written medical content and related
exhibitry (display cases, mounts, bases, etc.) for the specimens (“Exhibitions”), and

     WHEREAS, DHBTL currently has a sufficient number of anatomical samples necessary for
presentation in a public exhibition and desires to immediately enter into an agreement to lease the
Exhibition to Premier, and

     WHEREAS, the parties intend that the public exhibition of the Specimens will contribute to a
cultural and scientific exchange between western society and China, and will help the public in
western society to understand advanced science technology of China;

     WHEREAS, in accordance with the foregoing purpose, the public exhibitions of the Specimens
will be conducted in authorized venues such as science museums, science & technology centers,
exhibition & convention centers, or other venues operated by government related entities or public
or private foundations.

     WHEREAS, PREMIER wishes to acquire from DHBTL, and DHBTL wishes to grant to PREMIER, the
rights to present one five year tour (collectively the “Tour”) of the exhibition (the
“Exhibition”), of polymer preserved specimens (“Specimens”) exclusively controlled and leased by
DHBTL and subject to the terms and conditions of this Agreement, and

     WHEREAS, PREMIER is in the public exhibition business and desires to engage in exhibiting the
anatomical specimens provided by DHBTL, and

          NOW, THEREFORE, in consideration of the mutual covenants and conditions contained in this
Agreement, the parties hereto agree as follows:

	1.	 	Definitions.

          Except as otherwise indicated elsewhere in this Agreement, the following words and expressions
shall have the following meanings:

          1.1 “Specimens” shall mean any and all polymer preserved human anatomical specimens with the
serial number of EX2004A(BEIJING) documented and inventoried in Appendix “A”, attached hereto.

          1.2 “Exhibition” shall mean public and private presentation of Specimens for viewing and/or
education with the intention of selling admission tickets and/or for the purposes of creating other
revenue generating activities to generate a profit and shall include any or all of the Specimens
(EX2004A(BEIJING)), Exhibitry, promotional activities, advertising, and operations associated with
the Exhibition.

          1.3 “Condition Reports” shall mean reports to be generated by PREMIER that shall show the
current condition of the Specimens and the need for any further Conservation Procedures at any
given time.

          1.4 “Conservation Procedures” shall mean all procedures that are reasonably necessary to
maintain the integrity and condition of the Specimens in connection with the Exhibition of the
Specimens during the Term, as more fully described in the Condition Reports.

 

 

          1.5 “Exhibitry” shall be owned by Premier and include, display cases, mountings, props,
theatrical pieces, didactic and other panels, artwork, models, transportable walls and wall
covering, electronic, audiovisual and computer equipment and any and all other display items or
elements contained in the Exhibition, together with all drawings, plans, specifications and other
documentation relating thereto .

          1.6 “Parties” Shall mean DHBTL, Dr. Hong-Jin Sui, and Premier.

          1.7 “Supporting Material” shall mean material relating specifically to the production and
acquisition of the Specimens controlled or leased by DHBTL, including but not limited to all
original certification documents including the legal acquisition of the specimens by DHBTL
including but not limited to all supplemental documents related thereto including a certificate of
origin, representations that none of the specimens had AIDS, a donation certification from the
donor if available, photographs, video footage, etc.

          1.8 “Term” shall mean the period commencing upon signature of this agreement and expiring five
years (5) from date of signature, whereupon this Agreement shall automatically terminate without
further notice by either party to the other unless this Agreement has been extended pursuant to the
provisions of Section 6 hereto.

          1.9 “Venue(s)” shall mean the location(s) of the Exhibition.

          1.10 “Tour” shall mean the aggregate collection of all venues for the Exhibition.

          1.11 “Loaned Exhibitry” shall mean any and all exhibitry owned by DHBTL that is documented and
inventoried in Exhibit “B”, attached hereto.

	2.	 	Scope of Tour. 

          2.1
The Parties agree that PREMIER shall have the Exclusive rights to the
territories of North America, Central America, South America and the
Non-Exclusive rights to the rest of the world (Except China and
Korea) to exhibit the Specimens herein and to present exhibitions of
the Specimens during the Term hereof.

     2.1.1 In the event that DHBTL or Dr. Sui is approached by a 3rd party to
collaborate in a legitimate arms length transaction and the 3rd party proposes to use
his existing available specimens for a for profit exhibition outside of China or Korea then Premier
shall have the right to accept the same or similar acceptable terms as offered to DHBTL or Dr. Sui
by the 3rd party. Should Premier accept said terms then Premier is obligated to perform
on the terms or similar acceptable terms within12 months.

          2.2 During the Term hereof, PREMIER shall have the right to display Specimens for promotional
purposes. For the purposes of the foregoing, “promotional purposes” shall mean the display of a
specimen in an area where it can be viewed without the purchase of an admission ticket. The term
“promotional purposes” includes but is not limited to press conferences that are conducted to
publicize an Exhibition. Consistent with this Section, all Specimens presented at a press
conference will be presented in a dignified manner and handled properly.

          2.3 The working name for the Exhibition shall be “Bodies Revealed” or such other name or names
as may be determined from time to time by Premier.

          2.4 Subject to the provisions of Section 2.4.1 hereof, PREMIER shall locate and select the
Venues and design the Exhibition. PREMIER and DHBTL agree that the Exhibition shall be presented
with dignity and respect. In furtherance of the foregoing, PREMIER agrees that:

     2.4.1 The design and appearance of the Exhibition shall be created by PREMIER
at its own expense.

     2.4.2 Upon reasonable request from DHBTL, PREMIER will arrange for its key
design and other specialist personnel and DHBTL representatives to review the
progress of preparation of the Exhibition.

 

 

     2.4.3 Upon reasonable request of DHBTL, PREMIER will provide reasonable access
for DHBTL representatives to observe the preparation of the Venue for presentation
of the Exhibition(s).

          2.5 If there is a dispute or a disagreement or accusation of a material breach (“Dispute”)
between DHBTL and PREMIER in connection with this Agreement, a senior officer of both DHBTL and
PREMIER shall, within five (5) days of such Dispute, meet via teleconference or in person in good
faith to resolve such Dispute.

	3.	 	Obligations of PREMIER.

          3.1 Make all arrangements, and obtain all rights, permits and licenses as may be required, for
presentation of the Exhibition in the Venues, and in connection therewith, PREMIER will use its
commercially reasonable efforts to ensure that all improvements of the Venues will be completed
sufficiently in advance of the opening of the Exhibition so as to permit the Exhibition to commence
as scheduled;

          3.2 Commission and supervise all design and construction work relating to the presentation of
the Exhibition in each Venue including, but not limited to:

     3.2.1 All theatrical displays or devices that may be incorporated into the
Exhibition.

     3.2.2 All Specimen mountings and Specimen labels.

     3.2.3 All necessary galleries and ancillary areas, including furniture and
equipment for all areas or improvements that may be required to properly secure,
store, handle and display the Specimens and present them in a manner that will allow
the public to safely view them. It is agreed that all display cases and mountings
shall be of “Exhibition Quality”. “Exhibition Quality” shall mean the usual and
customary quality of a display case and mountings utilized in similar exhibitions.

          3.3 Develop and implement a comprehensive marketing, advertising, promotion and public
relations plan for the Exhibition. PREMIER shall own any such items it pays for and/or develops.

          3.4 Be responsible for the care and storage of the Specimens and Supporting Material so as to
protect the Specimens from the elements, including extreme lighting conditions, extreme temperature
fluctuation, extreme humidity fluctuation, unauthorized photography, filming, videotaping, or
handling by unauthorized personnel in a manner that could damage the Specimens.

          3.5 Provide full insurance coverage for the Specimens consistent with valuations provided by
DHBTL, as set forth on Exhibit “C”, from the time the Specimens are delivered by DHBTL to PREMIER
until thirty (30) days after the end of the Term, or the return of the Specimens to DHBTL,
whichever occurs first.

          3.6 Be responsible for all staffing, security and the daily operations of the Exhibition(s).

          3.7 Be responsible for all Specimen prepacking, packing, handling, security, insurance, export
and import customs charges and duties, and the transportation thereof.

          3.8 Be responsible for the installation and de-installation of the Exhibition, including the
Specimens.

          3.9 PREMIER shall have the right to refurbish, alter or otherwise modify elements of the
Display Items or Specimens for use within an Exhibition. In this event, the whole set of specimen
of EX2004A(BEIJING) should always be kept in a whole set, and can not be exhibited in two or more
venues without the permission of DHBTL or Dr. Sui, which permission shall not be unreasonably be
withheld. The Parties pre approve an exhibition in two or more venues incorporating EX2004A with
University of Michigan Pathology specimens and the Castings already in the possession of Premier.

 

 

          3.10 Be responsible for the safety and security of the Specimens, from the time the Specimens
are delivered by DHBTL to PREMIER and delivered back to DHBTL within thirty (30) days of the end of
this Agreement.

          3.11 PREMIER shall give DHBTL and its authorized representative reasonable access to each
Exhibition. PREMIER has the obligation to generate sufficient invitations as requested by DHBTL for
its representatives, employees, officers and directors, etc. to apply for visas.

	4.	 	Obligations of DHBTL.

          4.1 DHBTL will make available any and all Supporting Material as PREMIER shall reasonably
require and in a timely manor.

          4.3 Provide written descriptions and professional photographs and images of all of the DHBTL
specimens that are available to PREMIER as reflected on Exhibit A.

          4.4 DHBTL will, provide to PREMIER all available original certification documents of the legal
acquisition of the Specimens including . but not limited to all supplemental documents related
thereto including representations that none of the specimens had AIDS, a donation certification
from the donor if available, photographs, video footage, and a certificate of origin

          4.5 DHBTL shall not require PREMIER to include any specific specimen in an Exhibition.

          4.6 DHBTL shall help PREMIER to continue to seek an official endorsement of the exhibition
from a major medical institution acceptable to both parties.

          4.7 DHBTL has obtained and supplied Specimens only in a manner that is legal under the laws of
the People’s Republic of China, and has used its best efforts to not violate any international
restrictions that may deter PREMIER from exhibiting in other countries throughout the world.

          4.8 DHBTL shall conserve or repair as applicable any specimens that require laboratory
attention. All travel related expenses for repair purposes shall be paid by Premier.

          4.9 DHBTL shall exert its best efforts to protect the parties from competition with respect to
this tour of specimens as described herein.

          4.10 DHBTL will make available reasonable assistance in setting up the 1st
Exhibition in the Tour.

          4.11 Premier shall acquire all Exclusive exhibition rights During
the TERM to all of the existing Specimens EX2004A(BEIJING) and exhibitry as attached here to in Exhibit “A”

          4.12 DHBTL will allow Premier to use all Loaned Exhibitry as
attached here to in Exhibit “B” for one year from receipt by PREMIER from DHBTL.

          4.13 DHBTL represents and accordingly fully indemnifies Premier that
the set of specimens known as EX2004A(BEIJING) and the Loaned Exhibitry as
referenced herein in no way infringes on any existing patents or copyrights
including but not limited to those associated with Guther Von Hagens, Dow
Corning, or any related or unrelated companies throughout the world.

	5.	 	Lease and Percentage Payments. 

          5.1 PREMIER agrees to pay for the use of Specimens in the Exhibition calculated as follows:

 

 

          5.2 PREMIER agrees to pay and DHBTL agrees to accept a payment of ONE MILLION
DOLLARS US ($1,000,000 US) each year for the term of the agreement including all
extensions thereof to lease the Exhibition.

          5.3 PREMIER will transfer TWO HUNDRED and FIFTY THOUSAND DOLLARS US
($250,000 US) into an escrow account which shall be released to DHBTL, upon
Departure of the specimens from DHBTL to Premier of the Exhibitry and the
Specimens more fully described in Exhibit “A” and “B” attached hereto to
PREMIER at a designated place outside of the People Republic of China.

          5.4 The additional 3 payments of TWO HUNDRED and FIFTY THOUSAND
DOLLARS US ($250,000 US) each will be transferred to DHBTL’s designated
account each quarter beginning 3 MONTHS after the initial payment.

          5.5 For each subsequent year PREMIER agrees to pay DHBTL ONE
MILLION DOLLARS US ($1,000,000 US) in 4 equal payments of TWO HUNDRED and FIFTY
THOUSAND DOLLARS US ($250,000 US) on a quarterly basis.

          5.7 Any and all payments under this Agreement shall be made in United States Dollar
(USD) or such other currency as may be mutually agreed between the Parties, and by wire
transfer to the account designated by DHBTL or in such other method as may be mutually
agreed between the Parties.

          5.8 If any payment is delayed for [thirty (30)] days or more without any justifiable
reason, such delay will be deemed a material breach of this Agreement.

	6.	 	Options to Extend.

DHBTL grants to PREMIER the following options:

          6.1 PREMIER is hereby granted five (5) annual options (the “Annual Option(s)”) to extend the
term of this Agreement for an additional period of one (1) year each (the “Extension Period”)
Extensions will be deemed to have been exercised unless PREMIER gives prior written notice to DHBTL
60 days prior to the expiration of the term.

          6.2 Whenever reference is made to the Term in this Agreement, such word shall mean and include
all Extension Periods if the Annual Options with respect thereto have been exercised.

	7.	 	Options for additional Specimens

          7.1 PREMIER will have the exclusive option to acquire and present a minimum of three
additional touring Exhibitions featuring the anatomical samples designed by Dr. Sui.

	 	a.	 	The first option shall apply to an exhibition that DHBTL expects to be
available no later than October 2005 (EX2004B). The lease of this second
Exhibition (EX2005B) will be the same or substantially similar to the conditions
contained in the lease of the first . The lease of the third Exhibition
(EX2005A) will be the same or substantially similar to the conditions contained in
the lease of the first Exhibition(EX2004A(BEIJING)).
	 
	 	b.	 	If Premier exercises any other the above mentioned options a separate
lease agreement will be signed 30 days prior to delivery and the initial payment
will be escrowed within 72 hours of written notice that specimens are ready for
delivery.

 

 

	8.	 	PREMIER agrees to protect, defend, and indemnify DHBTL and all related companies and
individuals from any claims that may arise by John Norman and his company, Exhibitions
International, as a result of this agreement conflicting with the pre-existing contract
entered into between Dr. Sui and or a company that he owns or controls and John Norman and/or
his company, Exhibitions International, attached hereto as Exhibit_. Such indemnity and
protection shall extend to all reasonable legal fees.
	 
	9.	 	Intentionally Deleted
	 
	10.	 	PREMIER Representations and Warranties.

PREMIER hereby represents and warrants that:

          10.1 It is a Florida corporation and has the right and the complete authority to enter into
this Agreement.

          10.2 PREMIER or any subsidiary has not entered into any agreement or granted any rights or
undertaken any obligations, and will not do so during the Term, that will violate this agreement.

          10.3 PREMIER shall not use the Specimens in a manner that might infringe on any
intellectual properties, copyrights, trade marks, etc. of any third party or parties.

	11.	 	DHBTL Representations and Warranties.

          11.1 DHBTL has the right and complete authority to enter into this Agreement and to undertake
the obligations set forth herein, including, but not limited to, any necessary shareholder and
board of directors approvals.

          11.2 DHBTL operates legally in China and is a valid and existing corporation in good standing
in its State of incorporation, as specified in the preamble to this Agreement.

          11.3 Except as otherwise expressly disclosed in or expressly permitted under this Agreement,
DHBTL or Dr. Sui, their heirs, executors, administrators, assigns, family members, agents,
predecessors and successors, present and former affiliates, subsidiaries, legal representatives,
principals, officers, directors, employees            have not assigned, licensed, leased or otherwise
conveyed any Specimens and shall not, during the Term of this Agreement, assign, license, lease or
otherwise convey any Specimens to any person, other than those stated in this Agreement, and have
not entered into any agreement or granted any rights or undertaken any obligations, other than
those stated in this Agreement and will not do so during the Term, that will or might violate its
agreements, or conflict with its obligations, hereunder.

          11.4 DHBTL has the right and authority to use and/or to assign the right and authority to
PREMIER to use all of the Specimens, trademarks, copyrights and other materials relating to the
Exhibition and the Tour. Prior to the effective date of this Agreement, and except as otherwise
expressly disclosed in or expressly permitted under this Agreement, DHBTL will not and has not
assigned, licensed or otherwise conveyed DHBTL’s right to use any or all of the Specimens of
EX2004A(BEIJING), trademarks, copyrights or other materials relating to the Exhibition and the Tour
during the Term.

          11.5 DHBTL and Dr. Sui represent and warrant that no Specimens provided herein infringe on any
intellectual property rights, copyrights, trademarks, etc. held by any third party or parties
throughout the world.

          11.6 DHBTL is the sole legal responsible party for the Specimens.

	12.	 	Indemnities.

          12.1 DHBTL agrees to indemnify, defend and hold harmless PREMIER, its subsidiaries, parent
companies, affiliates, agents, and assigns and their respective agents, its officers, employees,
and directors, from and against any and all losses, damages, liabilities, claims, demands, and
expenses that PREMIER may incur or be liable for as a result of any claim, or proceeding made or
brought against PREMIER based upon, arising out of, or in connection with DHBTL breach of any of
its representations, duties or obligations hereunder. Such indemnify will not be more than two
million US Dollars.

 

 

          12.2 PREMIER agrees to indemnify, defend and hold harmless DHBTL, its subsidiaries, parent
companies, affiliates, agents, and assigns and their respective agents, officers, employees, and
directors, from and against any and all losses, damages, liabilities, claims, demands, and expenses
that DHBTL may incur or be liable for as a result of any claim, or proceeding made or brought
against PREMIER based upon, arising out of, or in connection with PREMIER’ breach of any of its
representations, duties or obligations hereunder. Such indemnify will not be more than two million
US Dollars.

          12.3 Each party shall give the other party prompt notice of any claim or notice coming within
the purview of these indemnities. Upon the written request of any indemnitee, the indemnitor shall
assume the defense of any claim, demand or action against such indemnitee, and shall upon the
request of the indemnitee, allow the indemnitee to participate in the defense thereof, such
participation to be at the expense of the indemnitee. Settlement by the indemnitee without the
indemnitor’s prior written consent shall release the indemnitor from the indemnity as to the claim,
demand or action so settled.

	13.	 	Trademark Rights.

          Neither party, by virtue of this Agreement, shall obtain or claim any right, title or interest
in or to the other’s name, trademark or logo, except the right to use as specified herein and
hereby acknowledges and agrees that all such use shall inure to the benefit of the respective
owner. It is expressly agreed that PREMIER shall be the sole and exclusive owner of all trademarks
utilized for the Exhibition and of all Exhibition logos.

	14.	 	Termination.

          14.1 The parties may terminate this Agreement in the event that (a) either PREMIER, or DHBTL
fail to perform any material term, covenant or agreement to be observed or performed by them under
this Agreement, and such failure shall continue for twenty (20) days following written notice from
DHBTL or PREMIER subject to paragraph 2.5 above; (b) either PREMIER or DHBTL shall become insolvent
or admit their inability to pay their debts as they mature or shall both make an assignment for the
benefit of their creditors; (c) a proceeding in bankruptcy or for the reorganization of either
PREMIER or DHBTL the readjustment of any of their debts under the Bankruptcy Code or any other
laws, whether state or federal, for the relief of debtors shall be commenced by either PREMIER or
DHBTL, or shall be commenced against both PREMIER and DHBTL and not discharged within sixty (60)
days after the commencement thereof; or (d) a receiver or trustee shall be appointed for either
PREMIER or DHBTL for any substantial part of their assets, or any proceeding shall be instituted
for dissolution or the full or partial liquidation of either PREMIER or DHBTL.

          14.2 Within thirty (30) days of termination of the Agreement Term, PREMIER at the request of
DHBTL shall forthwith return to DHBTL or otherwise dispose of as DHBTL may direct all pamphlets,
literature, photographs, catalogues, advertising material, specifications, cost estimates and other
materials, documents and papers whatsoever belonging to DHBTL and sent to DHBTL relating to the
Exhibition (other than correspondence between the PREMIER and DHBTL) which PREMIER may have in its
possession or under its control, except that DHBTL shall have the right to retain one (1) copy of
each of the foregoing for archival purposes.

          14.3 If either party brings an action against the other to enforce any condition or covenant
of this Agreement or for breach of its obligations under this Agreement,

          14.4 Within 14 days of the Termination of this Agreement, PREMIER shall make the specimens
available to DHBTL for pick up and guarantee that the specimens are in good condition minus normal
wear and tear. Premier shall coordinate the logistics on behalf of Dr. Sui and DHBTL.

	15.	 	Non-Competition.

          15.1 DHBTL, agree that, during the Term hereof, it will not directly engage in any other business
relating to the presentation of an exhibition concerning Specimens (EX2004A (BEIJING), either as a
proprietor, partner, investor, shareholder, director, officer, employee, principal, agent, advisor,
or consultant.

	16.	 	Miscellaneous.

 

 

          16.1 Other Documents. Each of the parties hereto shall execute and deliver such other
and further documents and instruments, and take such other and further actions, as may be
reasonably requested of them for the implementation and consummation of this Agreement and the
transactions herein contemplated.

          16.2 Parties in Interest. This Agreement shall be binding upon and inure to the
benefit of the parties hereto, and the successors and assigns of all of them, but shall not confer,
expressly or by implication, any rights or remedies upon any other party.

          16.3 Notices. All notices required to be given under the terms of this Agreement
shall be in writing (including Email and facsimile transmissions, provided that a copy thereof is
also sent by certified or registered air mail on the same day as such email or facsimile
transmission) and shall be deemed to have been duly given if delivered to the addressee in person
(and receipted on a copy of such notice), or transmitted, or mailed by a nationally recognized
overnight delivery service or certified or registered air mail, return receipt requested, as
follows:

If to DHBTL, addressed to:

 

If to PREMIER, addressed to:

Premier Exhibitions, Inc.

3340 Peachtree Rd NE Suite 2250

Atlanta, GA 30326

Attention: Arnie Geller, President

Fax No.: (404) 842 2626

All such notices shall be effective upon the delivery thereof to the addressee in person or via
nationally recognized overnight delivery service or facsimile with documentary evidence of
delivery. Any party may change their respective addresses and fax numbers by giving notice as
herein provided.

          16.4 Entire Agreement. This Agreement contains the entire agreement relating to the
Tour between the parties and supersedes all prior agreements, understandings and writings between
the parties with respect to the subject matter hereof and thereof. Each party hereto acknowledges
that no representations, inducement, promises, or agreements, oral or otherwise, have been made by
any party, which is not embodied herein or in an exhibit hereto, and that no other Agreement,
statement or promise may be relied upon or shall be valid or binding. Neither this Agreement nor
any term hereof may be changed, waived, discharged or terminated orally. This agreement may be
amended or supplemented or any term hereof may be changed, waived, discharged or terminated by an
agreement in writing signed by all parties hereto.

          16.5 Assignability. This exhibit contained within this agreement cannot be assigned,
transferred, leased or sold to any other party, without the written consent of DHBTL. Not
withstanding PREMIER is free to assign, transfer, or lease these rights to any wholly owned
subsidiaries.

          16.6 Severability. If any provision of the Agreement shall be held invalid or
unenforceable, the remainder of this Agreement which can be given effect without such invalid or
unenforceable provision shall remain in full force and effect. If any provision is held invalid or
unenforceable with respect to particular circumstances, it shall remain in full force and effect in
all other circumstances.

          16.7 No Waiver. The waiver by any party hereto of any breach or violation of any
provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach.

          16.8 Intentionally Deleted

          16.9 Publicity. Each of the parties agree that no press announcement or press release
in connection with this Agreement shall be made unless the other party hereto shall have given its
written consent to such announcement (including the form thereof), which consent shall not be
unreasonably withheld.

 

 

          16.10 Confidentiality. DHBTL and PREMIER agree, as may be permitted by law, to use
their reasonable efforts not to divulge or permit or cause their officers, directors, stockholders,
employees or agents to divulge the substance of this Agreement except to their representatives and
attorneys or as may otherwise be required by law in the opinion of counsel for the party required
to make such disclosure. Additionally, during and after the Term of this Agreement, DHBTL and
PREMIER shall use reasonable efforts not to disclose to anyone for any reason, without the prior
written consent of the other, any marketing plans, strategies, Technology, Documentation, know how,
etc., results or other confidential information divulged to or learned by either party about the
other from any source whatsoever, unless and until such information has generally become available
to the public from sources other than the other party.

          16.11 Independent Parties. Nothing in this Agreement is intended to create, nor shall
anything herein be construed or interpreted as creating, an agency, a partnership, a joint venture
or any other relationship between DHBTL and PREMIER except as expressly set forth herein, and both
parties understand that, except as expressly agreed to herein, each shall be responsible for its
own separate debts, obligations and other liabilities.

          16.12 Remedies. Remedies provided to the parties by this Agreement are not exhaustive
or exclusive, but are cumulative of each other and in addition to any other remedies the parties
may have in law or equity.

          16.13 Survival of Representations. The representations, warranties, indemnification,
and confidentiality provisions set forth in this Agreement shall be continuing and shall survive
the expiration of the Agreement Term for a period of four (4) years.

          16.14 Headings. The captions and headings used herein are for convenience only and
shall not be construed as a part of this agreement.

          16.15 Counterparts. This agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which taken together shall constitute but one and the same
document.

          16.16 Governing Law. This Agreement is made and shall be governed in all respects,
including validity, interpretation and effect, by the laws of the State of Florida, USA, without
recourse to its conflict of laws principles. Any legal action or proceeding with respect to this
Agreement shall be brought exclusively in the court of the State of Florida, and by execution and
delivery of this Agreement, DHBTL, Dr. Sui and Premier hereby accepts for itself and in respect of
its property, generally and unconditionally, the jurisdiction of the aforesaid courts. DHBTL, Dr.
Sui and Premier hereby irrevocable waive, in connection with any such action or proceeding, (i)
trial by jury, (ii) any objection, including, without limitation, any objection to the laying of
venue or based on the grounds of forum non conveniens, which it may now or hereafter have to the
bringing of any such action or proceeding in such respective jurisdictions.

	17.	 	Intentionally Deleted.

          IN WITNESS WHEREOF, the parties have executed this Agreement and affixed their hands and
seal the day and year first above written.

 

ACCEPTED AND AGREED TO:

 

Hoffen Bio Technique Company Limited

	 	 	 
	 

	 	 
	 	 	 
	Dr. Shuyan Wang, President
	 	 

 

 

Premier Exhibitions 2005B-ATL, Inc.

	 	 	 
	 

	 	 
	 	 	 
	Arnie Geller, President & CEO
	 	 

 

Acknowledged by:

	 	 	 
	 

	 	 
	 	 	 
	Hong-Jin Sui (“Dr. Sui”)EX-10.7

 

EXHIBIT 10.7

     AMENDMENT NO. 2 TO STOCKHOLDERS AGREEMENT dated as of May 30, 2006 (this
“Amendment”), among Town Sports International Holdings, Inc., a Delaware corporation (the
“Company”), Town Sports International, Inc., a New York corporation (“TSI”), and
those of the Stockholders (as defined in the Stockolders Agreement referred to below) that are
signatory hereto (the Company, TSI and such Stockholders are herein referred to collectively as the
“Parties”).

RECITALS

     A. The Parties and certain other Stockholders have entered into that certain Stockholders
Agreement dated as of February 4, 2004, and Amendment No. 1 to the Stockholders Agreement dated as
of March 23, 2006 (the “Stockholders Agreement”).

     B. Each of the persons listed on Annex A to this Amendment have either (i) entered
into an Executive Stock Agreement with the Company and certain other parties or a joinder agreement
with the Company, and pursuant to such Executive Stock Agreements or joinder agreements, each
person listed on Annex A has acknowledged and agreed that such person is a party to the
Stockholders Agreement which governs and restricts such person’s ability to transfer any shares of
the Company’s capital stock and other matters relating to such person as a shareholder of the
Company or (ii) has otherwise agreed to be bound by the terms of the Stockholders Agreement.

     C. The Company has agreed to register the shares of common stock of the Company held by the
Canterbury Investors in connection with the Company’s planned Initial Public Offering.

     D. The Farallon Investors have agreed to purchase 1,300,000 shares of the common stock of the
Company held by the Canterbury Investors from the Canterbury Investors immediately after the
consummation of the Company’s planned Initial Public Offering.

     E. The Parties desire to waive certain provisions of the Stockholders Agreement in connection
with the purchase and sale.

     F. The Parties desire to amend the Stockholders Agreement in accordance with Section 10 of the
Stockholders Agreement.

AGREEMENT

     NOW, THEREFORE, on the basis of the preceding facts, and in consideration of the mutual
agreements and covenants set forth below and other good and valuable consideration, the receipt and
sufficiency of which hereby are acknowledged, the Parties agree as follows:

     1. Definitions. Unless the context otherwise requires, all capitalized and other
defined terms not defined in this Amendment shall have the respective meanings accorded to them in
the Stockholders Agreement.

     2. Amendment.

 

 

     (a) The Stockholders Agreement is hereby amended to provide that, for all purposes of the
Stockholders Agreement, each of the persons listed on Annex A shall be deemed, for purposes
only of the Stockholders Agreement, an “Executive”, as such term is defined in the Stockholders
Agreement.

     (b) Section 4(c) of the Stockholders Agreement is hereby amended in its entirety to read as
follows following the consummation of the Company’s Initial Public Offering:

     “(c) Permitted Transfers. The restrictions contained in
this Section 4 shall not apply with respect to any Transfer of
Stockholder Shares (or Preferred Shares, to the extent this Section
4 applies to Preferred Shares) by any Stockholder (i) in the case of
an individual Stockholder, pursuant to applicable laws of descent
and distribution or among such Stockholder’s Family Group, (ii) in
the case of holders of the BRS Shares and its Permitted Transferees,
(A) among their Affiliates, partners and employees (provided that in
the case of a distribution to BRS’ partners, such distribution shall
be made pro rata to all such partners in accordance with the terms
of its agreement of limited partnership), (B) to any employee,
prospective employee, director or prospective director of the
Company or any Subsidiary of the Company as incentive compensation,
(C) to any former or prospective employee, director or prospective
director of BRS or any Affiliate of BRS or (D) to any BRS Investor
or BRS, (iii) in the case of any Canterbury Investor, any Rosewood
Investor, any Farallon Investor or CapitalSource and their
respective Permitted Transferees, (A) among their respective
Affiliates, members and partners (provided that in the case of a
distribution to any Farallon Investor’s, any Rosewood Investor’s,
any Canterbury Investor’s or any CapitalSource’s members or
partners, such distribution shall be made pro rata to all such
partners in accordance with the terms of their respective agreements
of limited partnership or limited liability operating agreements)
and (B) to any employee, director or prospective director of the
Company or any Subsidiary of the Company as incentive compensation,
(iv) in the case any Canterbury Investor or CapitalSource, in the
ordinary course of its business and in accordance with applicable
law, to an Affiliate of such Person or to one or more banks or other
financial institutions or entities which are not then in direct
competition with the Company only if such Canterbury Investor or
CapitalSource is required to do so pursuant to its applicable
agreement of limited partnership or limited liability operating
agreement or in connection with any dissolution of such Person
pursuant to its agreement of limited partnership or limited
liability operating agreement, (v) in the case of any Farallon
Investor, to another Farallon Investor; or (vi) by the Canterbury
Investors to the Farallon Investors pursuant to the terms of the
securities purchase

-2-

 

agreement by and among FCP, FCIP, FII, RRC, Canterbury Detroit
and Canterbury Mezzanine; provided, that in each case set forth
above, the rights and restrictions contained in this Section 4 shall
continue to be applicable to such Stockholder Shares or Preferred
Shares, as the case may be, after any such Transfer as if such
Stockholder Shares or Preferred Shares, as the case may be, were
held by the transferor; and provided further, that the transferees
of such Stockholder Shares or Preferred Shares, as the case may be,
shall have agreed in writing to be bound by the provisions of this
Agreement which affect the Stockholder Shares or Preferred Shares,
as the case may be, so transferred by executing a joinder in
substantially the form attached hereto as Exhibit A. All transferees
permitted under this Section 4(c) are collectively referred to
herein as “Permitted Transferees.” ”

     3. Governing Law. This Amendment shall be governed by, construed and enforced in
accordance with, the laws of the State of New York.

     4. Counterparts. This Amendment may be executed (including by facsimile transmission)
with counterpart signature pages or in any number of counterparts, each of which when executed
shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement.

     5. Bound Parties. The Stockholders Agreement is being amended by this Amendment
pursuant to Section 10 of the Stockholders Agreement and the amendment to the Stockholders
Agreement shall be effective upon the execution and delivery of this Amendment by the requisite
approval of the Company and those Stockholders specified in Section 10 of the Stockholders
Agreement.

     6. No Other Amendment. Except as expressly amended by this Amendment, the
Stockholders Agreement otherwise shall remain unaffected and shall be in full force and effect.

-3-

 

     IN WITNESS WHEREOF, the Parties hereto have executed and delivered this
Amendment as of the date first above written.

	 	 	 	 	 
	 	TOWN SPORTS INTERNATIONAL HOLDINGS, INC.

 	 
	 	By:  	/s/ Richard Pyle
 	 
	 	 	Name:  	Richard Pyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

	 	 	 	 	 
	 	TOWN SPORTS INTERNATIONAL, INC.

 	 
	 	By:  	/s/ Richard Pyle
 	 
	 	 	Name:  	Richard Pyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

[Signature page to Amendment No. 2 to the Stockholders Agreement]

 

 

Annex A

Bartlett, Dirk

Brinsmade, Alexandra

Brush, Vince

Bubolo, Kelley

Buckbee, Bruce

Buckley, Gerard

Calvo, Gerard

Choo, Jeanie

Corella, Jill

Dang, Long

Daniel, Matt

Derleth, Karl

DiMaggio, Anthony

Donnely, Allyson

Duncan, Rob

Fifield, Robert

Gallagher, Dan

Gerson, Susan

Gurtcheff, Chris

Hartop, David

Hatten, Doug

Haughey, Ann

Hennigan, Kate

Herbst, Robert

Hickey, Judith

Houren, Peggy

Hufcut, Lisa

Jones, Cheryl

Keightley, Tim

Kendig, Gary

Khan, Asif

Kraemer, John

Laing, Chee

Lande, Jeff

Marotta, Paul

McGovern, Maureen

Meltzer, Jodie

Napolitano, Frank

O’Hearen, Sean

Oberg, Nancy

Onofrio, Dan

Priestly, Lisa

Prue, Jenny

Rasulo, Pam

 

 

Richmond, Merrill

Rockett, Jo

Rockett, Kate

Ruta, Chris

Shane, Adam

Sherman, Seth

Sinert, Jenny

Smallwood, John

Stabile, Chris

Stephen, Randy

Sullivan, Barbara

Talty, Fred

Terlitsky, Mark

Verina, Daniel

Werner, Doug

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]